EDMONTON, Alberta--(BUSINESS WIRE)--Feb. 22, 2006--ViRexx Medical Corp. (TSX:VIR)(AMEX:REX), a company focused on immunotherapy treatments for certain cancers, chronic hepatitis B & C and embolotherapy treatments for tumors, today announced that Rajan George, Ph.D., Vice President Research and Development of ViRexx, made a presentation about the Company's Chimigen(TM) technology for hepatitis C at the 9th Annual Meeting of the Baculovirus & Insect Cell Culture held on February 20-22, 2006 in San Francisco. The presentation is titled "Properties of a Chimigen(TM) Vaccine Produced in Insect Cells for the Treatment of Chronic Hepatitis C Infections".
